About: Horizon Therapeutics     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:Organisation, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/c/7qH6eZrr6D

Horizon Therapeutics Public Ltd Co is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. In 2014 Horizon executed a tax inversion to move its legal headquarters to Ireland to avail of Ireland's low tax rates and beneficial corporate tax system. On May 2, 2019, shareholders of the company approved the change of the company's name to Horizon Therapeutics plc.

AttributesValues
rdf:type
rdfs:label
  • Horizon Therapeutics (fr)
  • Horizon Therapeutics (en)
  • Horizon Therapeutics (ru)
rdfs:comment
  • Horizon Therapeutics Public Limited Company (anciennement Horizon Pharma) est une entreprise pharmaceutique ayant ses principales activités aux États-Unis mais dont le siège social est en Irlande. Ses principaux produits sont liés au domaine de la douleur, de l'inflammation et de l'arthrite. (fr)
  • Horizon Therapeutics — международная фармацевтическая компания. Номинальная штаб-квартира расположена в Дублине (Ирландия), фактический центр операций в Чикаго (США). Специализируется на препаратах для лечения редких заболеваний. (ru)
  • Horizon Therapeutics Public Ltd Co is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. In 2014 Horizon executed a tax inversion to move its legal headquarters to Ireland to avail of Ireland's low tax rates and beneficial corporate tax system. On May 2, 2019, shareholders of the company approved the change of the company's name to Horizon Therapeutics plc. (en)
foaf:name
  • Horizon Therapeutics plc (en)
name
  • Horizon Therapeutics plc (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Horizon_Therapeutics_logo.svg
dct:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
thumbnail
hq location
  • * Dublin, Ireland * Lake Forest , Illinois, USA (en)
industry
key people
  • Andy Pasternak (en)
  • Jeffrey W. Sherman, M.D. (en)
  • Paul W. Hoelscher (en)
  • Timothy P. Walbert (en)
logo
  • File:Horizon Therapeutics logo.svg (en)
net income
num employees
predecessor
  • Horizon Pharma plc (en)
revenue
type
has abstract
  • Horizon Therapeutics Public Ltd Co is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. In 2014 Horizon executed a tax inversion to move its legal headquarters to Ireland to avail of Ireland's low tax rates and beneficial corporate tax system. On May 2, 2019, shareholders of the company approved the change of the company's name to Horizon Therapeutics plc. Horizon's drug portfolio is focused on treatments for thyroid eye disease (TED), gout, rare diseases, and inflammatory diseases. Horizon's portfolio includes Tepezza (teprotumumab), Krystexxa (pegloticase), Actimmune (interferon gamma), Duexis (ibuprofen + famotidine), Pennsaid (diclofenac, 2% topical), Rayos/Lodotra (prednisone), Vimovo (naproxen/esomeprazole magnesium), Buphenyl (sodium phenylbutyrate), Procysbi (cysteamine bitartrate), and Ravicti (glycerol phenylbutyrate). In 2016, the company became a member of the Pharmaceutical Research and Manufacturers of America (PhRMA). (en)
  • Horizon Therapeutics Public Limited Company (anciennement Horizon Pharma) est une entreprise pharmaceutique ayant ses principales activités aux États-Unis mais dont le siège social est en Irlande. Ses principaux produits sont liés au domaine de la douleur, de l'inflammation et de l'arthrite. (fr)
  • Horizon Therapeutics — международная фармацевтическая компания. Номинальная штаб-квартира расположена в Дублине (Ирландия), фактический центр операций в Чикаго (США). Специализируется на препаратах для лечения редких заболеваний. (ru)
ISIN
  • IE00BQPVQZ61 (en)
prov:wasDerivedFrom
page length (characters) of wiki page
founding year
Faceted Search & Find service v1.17_git147 as of Sep 06 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3331 as of Sep 2 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 55 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software